StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Elutia's operating cash flow for the twelve months ending Jun 30, 2026 was -$43.99M. For fiscal 2025 it was -$44.81M. The highest annual figure on record is -$7.23M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$44.81M–
FY2024Dec 31, 2024-$22.66M–
FY2023Dec 31, 2023-$21.76M–
FY2022Dec 31, 2022-$21.43M–
FY2021Dec 31, 2021-$15.45M–
FY2020Dec 31, 2020-$13.63M–
FY2019Dec 31, 2019-$7.23M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.46M–
Q1 FY2026Mar 31, 2026-$7.83M–
Q4 FY2025Dec 31, 2025-$24.81M–
Q3 FY2025Sep 30, 2025-$2.89M–
Q2 FY2025Jun 30, 2025-$8.23M–
Q1 FY2025Mar 31, 2025-$8.88M–
Q4 FY2024Dec 31, 2024-$12.26M–
Q3 FY2024Sep 30, 2024-$3.43M–
Q2 FY2024Jun 30, 2024-$4.33M–
Q1 FY2024Mar 31, 2024-$2.64M–
Q4 FY2023Dec 31, 2023-$9.08M–
Q3 FY2023Sep 30, 2023-$5.12M–
Q2 FY2023Jun 30, 2023-$2.39M–
Q1 FY2023Mar 31, 2023-$5.17M–
Q2 FY2022Jun 30, 2022-$10.70M–
Q1 FY2022Mar 31, 2022-$7.35M–
Q4 FY2021Dec 31, 2021-$6.39M–
Q3 FY2021Sep 30, 2021-$3.10M–
Q2 FY2021Jun 30, 2021-$787.00K–
Q1 FY2021Mar 31, 2021-$5.17M–
Q4 FY2020Dec 31, 2020-$5.37M–
Q3 FY2020Sep 30, 2020-$1.23M–
Q2 FY2020Jun 30, 2020-$3.99M–
Q1 FY2020Mar 31, 2020-$3.04M–
Q4 FY2019Dec 31, 2019-$2.57M–

More Elutia figures

See a number that looks wrong?